NASDAQ: LNTH
Lantheus Holdings, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
After hours: $98.00(-1.65%) · as of 7:34 PM ET
Market Cap
$6.49B
52w High
$111.86
52w Low
$47.25
P/E
23.49
Volume
1.01M
Outstanding Shares
65.11M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 39.96% over the last year. Revenue grew 0.62% over the trailing twelve months. Operating margin moved from 29.44% to 18.76%. Free cash flow declined 21.03% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 18.76%. A decisive move in revenue — currently up 0.62% — would be the clearest signal to resolve the ambiguity.
Company profile
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
13
Buy
4
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 6, 2026
Q3 FY26 · EPS est $1.29 · Revenue est $362.45M
View